Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy

3

Suggested Citation

Kiatiwat P., Sangasapaviliya A., Pradubpongsa P., Sangkanjanavanich S., Chiewchalermsri C., Jacquet A., Jaisupa N., Jindarat S., Boonpiyathad T., Mitthamsiri W. Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy. Allergy: European Journal of Allergy and Clinical Immunology (2023). doi:10.1111/all.15669 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/81963